Relief Therapeutics Holding Stock Price on November 21, 2024
| RLFTY Stock | USD 4.80 0.20 4.00% |
If you're considering investing in Relief OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Relief Therapeutics stands at 4.80, as last reported on the 20th of December, with the highest price reaching 4.80 and the lowest price hitting 4.46 during the day. Relief Therapeutics is very risky given 3 months investment horizon. Relief Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.49% are justified by taking the suggested risk. Use Relief Therapeutics Risk Adjusted Performance of 0.1154, semi deviation of 6.38, and Coefficient Of Variation of 748.02 to evaluate company specific risk that cannot be diversified away.
Relief OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Relief |
Sharpe Ratio = 0.1386
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | RLFTY | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.76 actual daily | 95 95% of assets are less volatile |
Expected Return
| 1.49 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Relief Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relief Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Lexaria Bioscience Headline on 21st of November 2024
Disposition of 200000 shares by Richard Christopher of Lexar... by Richard Christopher
Filed transaction by Lexaria Bioscience Corp Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Relief Therapeutics Valuation on November 21, 2024
It is possible to determine the worth of Relief Therapeutics on a given historical date. On November 21, 2024 Relief was worth 5.95 at the beginning of the trading date compared to the closed value of 5.98. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Relief Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Relief Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Relief Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Relief Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 5.71 | 5.84 | 5.70 | 5.84 | 553.00 | |
11/21/2024 | 5.95 | 5.98 | 5.95 | 5.98 | 211.00 |
| 5.98 | 5.98 | 5.98 | 5.98 | 1.00 |
| Backtest Relief Therapeutics | | | Relief Therapeutics History | | | Relief Therapeutics Valuation | Previous | Next |
Relief Therapeutics Trading Date Momentum on November 21, 2024
| On November 22 2024 Relief Therapeutics Holding was traded for 5.98 at the closing time. The highest daily price throughout the period was 5.98 and the lowest price was 5.98 . There was no trading activity during the period 1.0. Lack of trading volume on 11/22/2024 did not cause price change. The trading delta at closing time to current closing price is 14.72% . |
Relief Therapeutics Fundamentals Correlations and Trends
By evaluating Relief Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Relief Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Relief financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Relief Therapeutics OTC Stock history
Relief Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relief is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relief Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relief Therapeutics stock prices may prove useful in developing a viable investing in Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. Relief Therapeutics is traded on OTC Exchange in the United States.
Relief Therapeutics OTC Stock Technical Analysis
Relief Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Relief Therapeutics Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Relief Therapeutics Holding cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Relief Therapeutics December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Relief Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relief Therapeutics shares will generate the highest return on investment. By undertsting and applying Relief Therapeutics otc stock market strength indicators, traders can identify Relief Therapeutics Holding entry and exit signals to maximize returns
Relief Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Relief Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relief OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relief to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1154 | |||
| Jensen Alpha | 1.39 | |||
| Total Risk Alpha | 1.1 | |||
| Sortino Ratio | 0.1471 | |||
| Treynor Ratio | 1.49 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Relief OTC Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.